0.00 33.33
Prev Close 0.00
Open 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Volume 88.48M
Exchange OTC
Shares Outstanding 2436.31B
Market Cap 1.46M
Div & Yield N.A. (N.A)

BioElectronics' Drug-free ActiPatch® Pain Therapy

Highlighted in UK's Express Newspaper on Dangers of Excessive Drug Use

BioElectronics President Interviewed By The

Discusses Bioelectronics Mitigation of Chronic Pain and Drug Use

BioElectronics Drug-free Chronic Pain Therapy Observation Study Results

61% Pain Reduction & Decreases Medication Use in 86% (including opioids)

BioElectronics Announces Oxford University Sponsored Study

ActiPatch® Therapy for Chronic Low Back Pain

BioElectronics Expands In The UK Market

Leading UK Retailer, Superdrug to market and sell ActiPatch® Pain Therapy

BioElectronics Supports Arthritis Campaign

Osteoarthritis is the Most Common Cause of Disability

BioElectronics Reports Stronger Second Quarter Results

Publishes Market Analysis of its Try & Tell Survey That Predicts Strong Ongoing Sales

BioElectronics Files FDA Premarket Notification For ActiPatch® Therapy

The Most Innovative Treatment for Chronic Pain

UpTick News Wire Radio Show Will Interview BioElectronics' CEO Andrew Whelan

Topics will Include UK Progress and New Clinical Publications